TRIAMCINOLONE ACET 400 MG/10 ML
TRIAMCINOLONE ACETATE 400 MG/10 ML, a generic anti-inflammatory steroid, has an acquisition cost of $3.65, though hospitals typically charge patients significantly more than this wholesale price.
About the analyst
Kevin Nyk analyzes hospital pricing data at BillRazor Research. He specializes in Medicare reimbursement patterns and chargemaster pricing across U.S. hospitals. Expertise: hospital pricing, Medicare rates, chargemaster analysis.
Triamcinolone acetonide is an injectable corticosteroid used to treat inflammatory conditions such as arthritis, allergic reactions, and certain skin disorders. This generic formulation typically processes under HCPCS code J3300 series, with reimbursement varying significantly between inpatient and outpatient billing scenarios.
No credit card required. Results in 60 seconds.
Related pricing data
Data source: National Average Drug Acquisition Cost (NADAC) survey, published by CMS. HCPCS drug pricing codes from Medicare Part B Drug Average Sales Price file.
What NADAC means: The average price pharmacies pay to acquire this drug from wholesalers. Hospital charges for the same drug are typically higher due to facility fees, compounding, and administration costs.
Limitations: NADAC reflects pharmacy acquisition cost, not patient out-of-pocket cost. Insurance copays, formulary tiers, and manufacturer rebates affect what patients actually pay.